Did anyone attend the call for SVPs post the Q2 earnings announcement- it seemed like you could see daggers exchanged via looks and demeanour. The CFO and CRO rivalry has been evident for a while - but it blew my mind how cleverly one made a reference to the comments posted here which are mostly unfavourable for the CRO. The company’s recent stance on performance and launching new products without fixing old ones seems precarious. Q3 will tell how much of an impact if any the Focus event and the new marketing investment had.
There are no replies in this thread yet. Be the first to post a reply below: